Different therapeutic practices for treating cancers have significantly evolved to compensate
and/or overcome the failures in conventional methodologies. The demonstrated potentiality …

Since the ground-breaking discovery of RNA interference (RNAi), scientists have made
significant progress in the field of small interfering RNA (siRNA) treatments. Due to severe …

Hepatic tumors present a formidable challenge in cancer therapeutics, necessitating the
exploration of novel treatment strategies. In recent years, targeting the immune system has …

Multidrug resistance (MDR) is a problem that is often associated with a poor clinical outcome
in chemotherapeutic cancer treatment. MDR may potentially be overcome by utilizing …

Tumor development and metastasis are intimately associated with the tumor
microenvironment (TME), and it is difficult for vector-restricted drugs to act on the TME for …

Cancer is one of the leading causes of death around the world with major side effects for
existing therapies. The current study was aimed to extract pigments from microbial isolates …

Nonviral vectors, such as liposomes, offer potential for targeted gene delivery in cancer
therapy. Liposomes, composed of phospholipid vesicles, have demonstrated efficacy as …

Doxorubicin (DOX) is a commonly used antitumor drug. However, it may cause severe
cardiotoxicity, apoptosis being a major change. A recent report indicates that miR-147 …

As one of the well-known anticancer drugs, methotrexate (MTX) has been limited in clinical
application due to its side effects on normal tissues. This study focused on the one-step …

Metastasis is considered the major cause of unsuccessful cancer therapy. The metastatic
development requires tumor cells to leave their initial site, circulate in the blood stream …